reprai, founded in 2024 by Didem Aral and Özhan Öztürk, develops artificial-intelligence software that helps pharmaceutical firms personalize and optimize their interactions with doctors and other healthcare professionals. Its models analyze data to deliver the right message through the right channel at the right time, boosting campaign performance and return on investment while remaining fully compliant with industry regulations. The platform also supplies a measurable digital-marketing infrastructure that streamlines channel selection and budget allocation. With the latest capital, the U.S.–based startup plans to expand across the American and European markets, increase its market share, and enhance its underlying AI technology. Management emphasizes scalable growth in strategic geographies and aims to set new standards for the sector’s digital engagement. No operating metrics such as revenue or user counts were disclosed in the article.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2025